Recommendations for Standardizing MRI-based Evaluation of Perianal Fistulizing Disease Activity in Pediatric Crohn's Disease Clinical Trials.
Eileen CrowleyChristopher MaLeonard GuizzettiGuangyong ZouPeter J LewindonMichael S GeeJeffrey S HyamsMichael J RosenDaniel von AllmenAnthony de Buck van OverstraetenLisa M ShackeltonJulie RemillardLauren SchleicherJonathan R DillmanJordi RimolaStuart A TaylorJoel G FletcherPeter C ChurchBrian G FeaganAnne M GriffithsVipul JairathMary-Louise C GreerPublished in: Inflammatory bowel diseases (2023)
Outcomes of treatment of perianal fistulizing disease in children must include MRI. Existing multi-item measures, specifically the mVAI and MAGNIFI-CD, can be adapted and used for children. Further research to assess the operating properties of the indices when used in a pediatric patient population is ongoing.
Keyphrases
- disease activity
- rheumatoid arthritis
- clinical trial
- systemic lupus erythematosus
- magnetic resonance imaging
- young adults
- contrast enhanced
- rheumatoid arthritis patients
- ankylosing spondylitis
- juvenile idiopathic arthritis
- diffusion weighted imaging
- randomized controlled trial
- computed tomography
- hidradenitis suppurativa
- clinical practice
- type diabetes
- adipose tissue
- open label